• FAST Enables Food-Grade Nanoparticle Delivery of Nutraceutic

  2026-06-26

  The reference study introduces Facilitated Self-Assembling Technology (FAST) as a clean-label, food-grade method for generating stable, bioavailable nanoparticles of key nutraceuticals. This innovation addresses long-standing solubility and safety challenges, supporting scalable, regulatory-compliant oral delivery systems for antioxidants and bioactives.

• JIB-04 Inhibits Colorectal Cancer Stem Cells via Wnt/β-Caten

  2026-06-26

  This study identifies JIB-04, a pan-histone demethylase inhibitor, as a selective agent targeting colorectal cancer stem cells by suppressing Wnt/β-catenin signaling. The findings highlight mechanistic links between epigenetic modulation and stemness in colorectal cancer, with implications for developing more precise anti-CSC therapies.

• Dabigatran in Experimental Coagulation: Beyond the Standard

  2026-06-25

  Explore the advanced scientific principles and nuanced applications of Dabigatran in coagulation research. This article uncovers unique mechanistic insights and practical assay guidance, setting it apart from conventional Dabigatran content.

• Nystatin (Fungicidin): Protocols and Performance in Antifung

  2026-06-25

  Nystatin (Fungicidin) from APExBIO unlocks high-fidelity antifungal assays, empowering researchers to dissect Candida and Aspergillus models with reproducible, data-driven precision. This guide details experimental workflows, troubleshooting insights, and the latest evidence on mechanistic selectivity—optimizing your bench-to-publication antifungal investigations.

• Procainamide Hydrochloride Reduces Cisplatin Hepatotoxicity

  2026-06-24

  This study demonstrates that procainamide hydrochloride can significantly mitigate cisplatin-induced liver toxicity in rats by altering platinum distribution and promoting the formation of less toxic platinum complexes. These findings offer mechanistic insight and practical parameters for researchers investigating chemoprotective strategies in oncology.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Use Guide

  2026-06-23

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive, specific detection of rabbit IgG in immunofluorescence, immunohistochemistry, and related imaging assays. This reagent is best applied in research workflows requiring robust signal amplification and reliable fluorescent labeling, but it is not suitable for diagnostic or clinical use, nor where direct paper validation is mandatory.

• CCL7+ Macrophages Mediate Immunotherapy Resistance in CRC

  2026-06-23

  This study uncovers how CCL7-expressing tumor-associated macrophages (TAMs) foster immune checkpoint inhibitor resistance in colorectal cancer by modulating macrophage and CD8+ T cell infiltration. The mechanistic insights into CCL7-driven immune suppression offer actionable targets for enhancing immunotherapy efficacy in CRC.

• β-Amanitin for RNA Polymerase II Studies: Protocols & Advanc

  2026-06-22

  β-Amanitin, a potent RNA polymerase II inhibitor, is indispensable for dissecting eukaryotic transcription and gene regulation. This guide delivers practical protocols, troubleshooting strategies, and cutting-edge applications, empowering researchers to achieve high-fidelity results in transcriptional regulation research and toxicology.

• Rocilinostat (ACY-1215): HDAC6 Inhibition in Myeloma & Neuro

  2026-06-22

  Rocilinostat (ACY-1215) stands out as a precise tool for dissecting HDAC6 function in both cancer and neurodevelopmental research. This guide details optimized protocols, highlights novel cross-domain applications, and delivers troubleshooting strategies to maximize reproducibility in advanced cell-based assays.

• CCT007093: Precision PPM1D Inhibitor for Pathway Dissection

  2026-06-21

  CCT007093 from APExBIO delivers selective PPM1D inhibition, enabling rigorous dissection of the P38 MAPK signaling pathway in cancer and acute kidney injury models. This guide details applied protocols, troubleshooting strategies, and translational insights grounded in recent peer-reviewed findings.

• Belinostat (PXD101): HDAC Inhibition and Epigenetic Cancer C

  2026-06-20

  Belinostat (PXD101) is a potent pan-histone deacetylase inhibitor with nanomolar IC50, enabling robust epigenetic modulation and proliferation arrest in multiple cancer models. Its distinctive mechanism and validated in vitro efficacy make it a benchmark tool for cancer research. APExBIO supplies Belinostat (PXD101) as SKU A4096 for non-clinical scientific use.

• A-1331852 (SKU B6164): Optimizing BCL-XL Inhibition in Apopt

  2026-06-19

  This article delivers a scenario-driven, evidence-based exploration of how A-1331852 (SKU B6164) enables reproducible, high-sensitivity apoptosis and cytotoxicity assays for cancer research. Drawing on peer-reviewed literature and validated product specifications, researchers will find actionable guidance for experimental design, protocol optimization, and reliable BCL-XL inhibition. With practical Q&A grounded in real laboratory needs, this resource empowers bench scientists to achieve greater confidence and data quality using A-1331852.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry

  2026-06-19

  Wang et al. (2018) identify clathrin-mediated endocytosis as the primary pathway for cellular entry of the type III grass carp reovirus (GCRV104), clarifying a key aspect of viral pathogenesis in aquaculture. Their inhibitor analysis provides mechanistic insights relevant for antiviral strategy development and comparative pathogen entry research.

• DiscoveryProbe Protease Inhibitor Library: Applied Screening

  2026-06-18

  The DiscoveryProbe Protease Inhibitor Library empowers high-throughput and high-content screening with 825 validated, cell-permeable compounds. Flexible formats and robust quality assurance make it a pivotal tool for dissecting protease biology in cancer, apoptosis, and infectious disease research.

• Dehydroepiandrosterone (DHEA): Mechanistic Insight and Next-

  2026-06-18

  Explore how Dehydroepiandrosterone (DHEA) bridges mechanistic innovation and translational strategy in neuroprotection and ovarian research. This article delves into the molecular rationale, cutting-edge validation, and actionable guidance for deploying DHEA in advanced experimental contexts, while positioning APExBIO’s DHEA as the gold standard for reproducibility and impact.

16262 records 1/1085 page Next 12345 下5页 Last page